A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
Recruiting · NCT07665879 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-07-16 | NCT07665879 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CTC GoCo | Mölndal | Sweden | 1 |
| Profil Institut für Stoffwechselforschung | Neuss | Germany | 3 |